Genaera Corp Watch

from 10-K 2 pages Amendment No. 1 to the Fifth Amended and Restated Certificate of Incorporation of Genaera Corporation

from 8-K 2 pages Amendment to the Bylaws of Genaera Corporation Dated: November 29, 2007

from 10-Q 47 pages Fifth Amended and Restated Certificate of Incorporation of Genaera Corporation

from 10-Q ~50 pages Third Restated Certificate of Incorporation

from 8-K ~10 pages Certificate of Designation Series C-2 06/09/2003

from 8-K ~10 pages Certificate of Designations - Series C-1 Preferred Stock 06/09/2003

from 8-K ~10 pages Certificate of Designation - Series C-2

from 8-K ~10 pages Certificate of Designation - Series C-1

from 10-Q ~20 pages Amended and Restated By-Laws of the Registrant

from 10-Q ~20 pages 2nd Restated Certificate of Incorporation

from 10-K ~20 pages Articles of Incorporation or Bylaws

from 10-Q 1 page Certificate of Amendment of the Restated Certificate of Incorporation

from 10-Q ~10 pages Certificate of Designations

from 10-Q 1 page Certificate of Ownership and Merger

from 10-K405 ~10 pages Amended and Restated By-Laws

from 10-K405 1 page <page> 1 Certificate of Amendment of Restated Certificate of Incorporation of Magainin Pharmaceuticals Inc. Magainin Pharmaceuticals Inc., a Delaware Corporation (The "Corporation"), Does Hereby Amend Its Restated Certificate of Incorporation Pursuant to the Provisions of Section 242 of the Delaware General Corporation Law as Set Forth Below: 1. the First Paragraph of Article Fourth of the Restated Certificate of Incorporation Is Hereby Amended to Read in Its Entirety as Follows: "Fourth: The Total Number of Shares of All Classes of Stock Which the Corporation Shall Have Authority to Issue Is 54,211,031, Consisting of 9,211,031 Shares of Convertible Preferred Stock, $.001 Par Value (The "Preferred Stock"), and 45,000,000 Shares of Common Stock, $.002 Par Value (The "Common Stock")." 2. the Corporation Hereby Certifies That the Amendment Set Forth in Paragraph 1 Above Has Been Duly Adopted in Accordance With the Provisions of Section 242 of the Delaware General Corporation Law. in Witness Whereof, the Corporation Has Caused This Certificate of Amendment of the Restated Certificate of Incorporation to Be Duly Adopted in Accordance With the Provisions of Section 242 of the Delaware General Corporation Law and to Be Executed in Its Corporate Name on the 20th Day of May, 1996. Magainin Pharmaceuticals Inc. By: /S/ Jay Moorin Jay Moorin President and Chief Executive Officer